Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study-Reference-Cited by-同舟云学术

Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study

Published:2023-01-23 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Onwuzo Somtochukwu,Boustany Antoine,Khaled Abou Zeid Hadi,Hitawala Asif,Almomani Ashraf,Onwuzo Chidera,Lawrence Favour,Mascarenhas Monteiro Jessy,Ndubueze Chidera,Asaad Imad

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference17 articles.

1. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing;Lima JJ;Clin Pharmacol Ther,2021

2. Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression;Scarpignato C;BMC Med,2016

3. National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017;Mishuk AU;J Am Pharm Assoc (2003),2020

4. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009;Rotman SR;PLoS One,2013

5. Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies;Shastri SA;Med Pharm Rep,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects;Journal of Clinical Medicine;2024-07-08

2. Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR;Euroasian journal of hepato-gastroenterology;2024-06-12

3. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review;World Journal of Gastroenterology;2024-06-07